{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:43:30Z","timestamp":1792413810550,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05997-0","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:27:56Z","timestamp":1792366076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of antiseptic drug candidate pyridosept in preclinical in vivo toxicity studies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2109-569X","authenticated-orcid":false,"given":"Renata","family":"Kazakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfiya","family":"Fakhrieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Agafonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bulatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kirichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Malanyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milana","family":"Mansurova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilnur","family":"Ganiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Komcharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Raginov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Sapozhnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Shtyrlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurii","family":"Shtyrlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"1","key":"5997_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib A, Archie SR, Karamyan VT (2019) Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm Res 37(1):12. https:\/\/doi.org\/10.1007\/s11095-019-2745-x","journal-title":"Pharm Res"},{"key":"5997_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/01926230390183751","volume":"31","author":"CL Bregman","year":"2003","unstructured":"Bregman CL, Adler RR, Morton DG et al (2003) Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies: a proposal of the Society of Toxicologic Pathology (STP). Toxicol Pathol 31:252\u2013253. https:\/\/doi.org\/10.1080\/01926230390183751","journal-title":"Toxicol Pathol"},{"key":"5997_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10937404.2017.1408552","volume":"21","author":"SM Choi","year":"2018","unstructured":"Choi SM, Roh TH, Lim DS et al (2018) Risk assessment of benzalkonium chloride in cosmetic products. J Toxicol Environ Health B Crit Rev 21:8\u201323. https:\/\/doi.org\/10.1080\/10937404.2017.1408552","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"5997_CR4","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.tiv.2006.07.006","volume":"20","author":"T Deutschle","year":"2006","unstructured":"Deutschle T, Porkert U, Reiter R et al (2006) In vitro genotoxicity and cytotoxicity of benzalkonium chloride. Toxicol In Vitro 20:1472\u20131477. https:\/\/doi.org\/10.1016\/j.tiv.2006.07.006","journal-title":"Toxicol In Vitro"},{"key":"5997_CR5","unstructured":"Gill MW, Wagner CL (1990) Ninety-day subchronic dermal toxicity study with alkyl dimethyl benzyl ammonium chloride (ADBAC) in rats. Unpublished report number 52\u2013623. Bushy Run Research Center, Export, PA, US"},{"key":"5997_CR6","unstructured":"Global Antiseptics and Disinfectants Market Size (2024) Share, and COVID-19 Impact Analysis, By Type (Quaternary Ammonium Compound, Enzyme, Chlorine Compounds, Alcohols, Aldehyde Products and Others), By Product Application (Medical Devices, Enzymatic Cleaners, Surface Disinfectants, and Other), By Sales Channel Insights (B2B and FMCG), By End-User (Hospital and Clinics, Homecare, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 \u2013 2033.\u00a0https:\/\/www.sphericalinsights.com\/reports\/antiseptics-and-disinfectants-market. Accessed 19 Dec 2025"},{"issue":"2","key":"5997_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S (2022) Ocular benzalkonium chloride exposure: problems and solutions. Eye (Lond) 36(2):361\u2013368. https:\/\/doi.org\/10.1038\/s41433-021-01668-x","journal-title":"Eye (Lond)"},{"key":"5997_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-303-9_1","volume-title":"Mood and anxiety related phenotypes in mice, Neuromethods","author":"TD Gould","year":"2009","unstructured":"Gould TD, Dao DT, Kovacsics CE (2009) \u2018The open field test.\u2019 In: Gould TD (ed) Mood and anxiety related phenotypes in mice, Neuromethods. Humana Press, Totowa, NJ, pp 1\u201320. https:\/\/doi.org\/10.1007\/978-1-60761-303-9_1"},{"key":"5997_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2023.104217","volume":"102","author":"HV Hereira-Mar\u00f3stica","year":"2023","unstructured":"Hereira-Mar\u00f3stica HV, Ames-Sibin AP, Pateis VO, de Souza GH, Silva BP, Bracht L, Comar JF, Peralta RM, Bracht A, S\u00e1-Nakanishi AB (2023) Harmful effects of chlorhexidine on hepatic metabolism. Environ Toxicol Pharmacol 102:104217. https:\/\/doi.org\/10.1016\/j.etap.2023.104217","journal-title":"Environ Toxicol Pharmacol"},{"key":"5997_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2026.119751","volume":"310","author":"Y Huang","year":"2026","unstructured":"Huang Y, Ding C, Wang S, Shi Y, Zheng W, Lin H, Ren X, Ge R, Shangguan W (2026) Structural determinants of oxygenated benzalkonium-like disinfectants as human and rat 5\u03b1-reductase 1 inhibitors: integrated SPR binding analysis with docking. Ecotoxicol Environ Saf 310:119751. https:\/\/doi.org\/10.1016\/j.ecoenv.2026.119751","journal-title":"Ecotoxicol Environ Saf"},{"key":"5997_CR11","unstructured":"ICH S2(R1) (2012) ICH guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. EMA\/CHMP\/ICH\/126642\/2008.\u00a0Available at: https:\/\/database.ich.org\/sites\/default\/files\/S2_R1_Guideline.pdf"},{"key":"5997_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.29296\/25419218-2020-07-09","volume":"69","author":"BA Imamaliev","year":"2020","unstructured":"Imamaliev BA, Fayzieva ZT (2020) Investigation of the subacute toxicity (cumulation) of the liquid extract Phytoallergoderm. Farmaciya (Pharmacy) 69:51\u201356. https:\/\/doi.org\/10.29296\/25419218-2020-07-09","journal-title":"Farmaciya (Pharmacy)"},{"key":"5997_CR13","first-page":"39","volume":"79","author":"RR Kazakova","year":"2016","unstructured":"Kazakova RR, Luong DT (2016) Anesthetics for magnetic resonance studies in rodents (systematic review of experimental results). Eksp Klin Farmakol 79:39\u201344","journal-title":"Eksp Klin Farmakol"},{"key":"5997_CR14","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.2174\/0109298673356654250122063321","volume":"32","author":"R Kazakova","year":"2025","unstructured":"Kazakova R, Iksanova A, Agafonova M et al (2025) Evaluation of antiseptic drug candidate pyridosept in preclinical in vitro studies. CMC 32:8171\u20138181. https:\/\/doi.org\/10.2174\/0109298673356654250122063321","journal-title":"CMC"},{"key":"5997_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-44037-3.00553-4","volume-title":"Reference module in biomedical sciences","author":"R Khupse","year":"2026","unstructured":"Khupse R, Isei MO, Basu Sarkar A (2026) Benzoxonium chloride. Reference module in biomedical sciences. Elsevier. https:\/\/doi.org\/10.1016\/B978-0-443-44037-3.00553-4"},{"key":"5997_CR16","unstructured":"Krivoshein JS, Rud\u2019ko AP (2001) Therapeutic preparation. Patent RU No. 2161961"},{"key":"5997_CR17","volume-title":"Sax\u2019s dangerous properties of industrial materials","author":"RJ Lewis","year":"2012","unstructured":"Lewis RJ (2012) Sax\u2019s dangerous properties of industrial materials. Wiley, New York"},{"key":"5997_CR18","first-page":"336","volume":"130","author":"RK Lim","year":"1961","unstructured":"Lim RK, Rink KG, Glass HG, Soaje-Echague E (1961) A method for the evaluation of cumulation and tolerance by the determination of acute and subchronic median effective doses. Arch Int Pharmacodyn Ther 130:336\u2013353","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"5997_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41579-023-00958-3","volume":"22","author":"J-Y Maillard","year":"2024","unstructured":"Maillard J-Y, Pascoe M (2024) Disinfectants and antiseptics: mechanisms of action and resistance. Nat Rev Microbiol 22:4\u201317. https:\/\/doi.org\/10.1038\/s41579-023-00958-3","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"5997_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1292\/jvms.24-0311","volume":"87","author":"A Matsuda","year":"2025","unstructured":"Matsuda A, Nakamura Y, Itoi T, Arai K, Kutara K, Sugimoto K, Maeta N (2025) Daily topical application of chlorhexidine gluconate to the skin in dogs and its impact on skin barriers and cytotoxicity. J Vet Med Sci 87(3):257\u2013262. https:\/\/doi.org\/10.1292\/jvms.24-0311","journal-title":"J Vet Med Sci"},{"key":"5997_CR21","unstructured":"Mironov AN (2012) Manual for conducting preclinical studies of drugs. Under the editorship of Mironov AN, Bunatyan ND et al., M., publishing house \u201cGrif and K\u201d"},{"key":"5997_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1383-5718(01)00292-3","volume":"513","author":"T Nishikawa","year":"2002","unstructured":"Nishikawa T, Haresaku M, Fukushima A, Nakamura T, Adachi K, Masuda M, Hayashi M (2002) Further evaluation of an in vivo micronucleus test on rat and mouse skin: results with five skin carcinogens. Mutat Res Genet Toxicol Environ Mutagen 513:93\u2013102. https:\/\/doi.org\/10.1016\/S1383-5718(01)00292-3","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"5997_CR23","unstructured":"OECD (1981) Test No. 411: subchronic dermal toxicity: 90-day study"},{"key":"5997_CR24","unstructured":"OECD (2002) Test No. 423: acute oral toxicity - acute toxic class method"},{"key":"5997_CR25","unstructured":"OECD (2017) Test No. 402: acute dermal toxicity"},{"key":"5997_CR26","unstructured":"OECD (2009) Test No. 403: acute inhalation toxicity"},{"key":"5997_CR27","unstructured":"Organon (2023) Safety data sheet. Betamethasone liquid formulation. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.organon.com\/docs\/product\/safety-data-sheets\/Betamethasone%20Liquid%20Formulation_IN_6N.pdf. Accessed 19 Dec 2025"},{"issue":"7","key":"5997_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10937404.2025.2503784","volume":"28","author":"TG Osimitz","year":"2025","unstructured":"Osimitz TG, Droege W (2025) Perspectives on safety of quaternary ammonium compounds (QACs). J Toxicol Environ Health B Crit Rev 28(7):535\u2013560. https:\/\/doi.org\/10.1080\/10937404.2025.2503784","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"5997_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/femsre\/fuaa012","volume":"44","author":"A Osmanov","year":"2020","unstructured":"Osmanov A, Farooq Z, Richardson MD, Denning DW (2020) The antiseptic Miramistin: a review of its comparative in vitro and clinical activity. FEMS Microbiol Rev 44:399\u2013417. https:\/\/doi.org\/10.1093\/femsre\/fuaa012","journal-title":"FEMS Microbiol Rev"},{"key":"5997_CR30","unstructured":"Patent RU 2641309 (2018) Antiseptic drug. https:\/\/patents.google.com\/patent\/RU2641309C1\/ru. Also as patents US11014934, CN111201231, EA038460B1, IN 392462"},{"key":"5997_CR31","unstructured":"Patent RU 2697848 (2017) Method of producing 5,8-(bis(methylene(n,n-dimethyl-n-dodecylammonium))-2-ethyl-4h-[1,3]dioxino[4,5-c]pyridinium dichloride https:\/\/patents.google.com\/patent\/RU2697848C1\/ru"},{"key":"5997_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ijerph2005010101","volume":"2","author":"BP Patlolla","year":"2005","unstructured":"Patlolla BP, Patlolla AK, Tchounwou PB (2005) Cytogenetic effects of 1,1-dichloroethane in mice bone marrow cells. Int J Environ Res Public Health 2:101\u2013106. https:\/\/doi.org\/10.3390\/ijerph2005010101","journal-title":"Int J Environ Res Public Health"},{"key":"5997_CR33","volume-title":"Handbook of pharmaceutical excipients","author":"RC Rowe","year":"2009","unstructured":"Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients, 6th ed. Pharmaceutical press, London","edition":"6th ed"},{"key":"5997_CR34","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1007\/s00044-017-2012-9","volume":"26","author":"SV Sapozhnikov","year":"2017","unstructured":"Sapozhnikov SV, Shtyrlin NV, Kayumov AR et al (2017) New quaternary ammonium pyridoxine derivatives: synthesis and antibacterial activity. Med Chem Res 26:3188\u20133202. https:\/\/doi.org\/10.1007\/s00044-017-2012-9","journal-title":"Med Chem Res"},{"key":"5997_CR35","volume-title":"Biocompatibility of dental materials","author":"G Schmalz","year":"2009","unstructured":"Schmalz G, Arenholt-Bindslev D (2009) Biocompatibility of dental materials. Springer, Berlin"},{"key":"5997_CR36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/1573406411666150504122930","volume":"11","author":"N Shtyrlin","year":"2015","unstructured":"Shtyrlin N, Sapozhnikov S, Koshkin S et al (2015) Synthesis and antibacterial activity of novel quaternary ammonium pyridoxine derivatives. MC 11:656\u2013665. https:\/\/doi.org\/10.2174\/1573406411666150504122930","journal-title":"MC"},{"key":"5997_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3864193","author":"NV Shtyrlin","year":"2016","unstructured":"Shtyrlin NV, Sapozhnikov SV, Galiullina AS et al (2016) Synthesis and antibacterial activity of quaternary ammonium 4-deoxypyridoxine derivatives. BioMed Res Int. https:\/\/doi.org\/10.1155\/2016\/3864193","journal-title":"BioMed Res Int"},{"key":"5997_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11172-019-2504-5","volume":"68","author":"YG Shtyrlin","year":"2019","unstructured":"Shtyrlin YG, Petukhov AS, Strelnik AD et al (2019) Chemistry of pyridoxine in drug design. Russ Chem Bull 68:911\u2013945. https:\/\/doi.org\/10.1007\/s11172-019-2504-5","journal-title":"Russ Chem Bull"},{"key":"5997_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184341","volume":"25","author":"NV Shtyrlin","year":"2020","unstructured":"Shtyrlin NV, Pugachev MV, Sapozhnikov SV et al (2020) Novel bis-ammonium salts of pyridoxine: synthesis and antimicrobial properties. Molecules 25:4341. https:\/\/doi.org\/10.3390\/molecules25184341","journal-title":"Molecules"},{"key":"5997_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s11055-017-0421-3","volume":"47","author":"PE Umryukhin","year":"2017","unstructured":"Umryukhin PE, Grigorchuk OS (2017) Behavior of rats in an open field test as a prognostic indicator of corticosterone levels before and after stress. Neurosci Behav Physi 47:456\u2013458. https:\/\/doi.org\/10.1007\/s11055-017-0421-3","journal-title":"Neurosci Behav Physi"},{"key":"5997_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.18356\/78285908-en","volume-title":"Globally Harmonized System of Classification and Labeling of Chemicals (GHS)","author":"United Nations","year":"2011","unstructured":"United Nations (2011) Globally Harmonized System of Classification and Labeling of Chemicals (GHS), 4th ed. United Nations, New York, NY, USA; Geneva, Switzerland, pp 109\u2013120","edition":"4th ed."},{"key":"5997_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s43856-021-00070-8","volume":"2","author":"HFG van Dijk","year":"2022","unstructured":"van Dijk HFG, Verbrugh HA (2022) Ad hoc advisory committee on disinfectants of the Health Council of the Netherlands. Resisting Disinfectants Commun Med (Lond) 2:6. https:\/\/doi.org\/10.1038\/s43856-021-00070-8","journal-title":"Resisting Disinfectants Commun Med (Lond)"},{"key":"5997_CR43","unstructured":"World Health Organization, eEML - Electronic Essential Medicines List., 2025. Available from: https:\/\/list.essentialmeds.org\/. Accessed 19 Nov 2025"},{"key":"5997_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/10915819309140642","volume":"12","author":"L Willis","year":"1993","unstructured":"Willis L (1993) Final report on the safety assessment of chlorhexidine\/chlorhexidine diacetate\/chlorhexidine dihydrochloride\/chlorhexidine digluconate. J Am Coll Toxicol 12:201\u2013223. https:\/\/doi.org\/10.3109\/10915819309140642","journal-title":"J Am Coll Toxicol"},{"key":"5997_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2026.112184","volume":"436","author":"M Wu","year":"2026","unstructured":"Wu M, Zhang S, Yan Z, Yang J, Yang H, Li J, Huang Z, Yuan J (2026) Integrating network toxicology, molecular simulation and experimental validation to decipher the role of CXCR4 in benzalkonium chloride-induced parakeratosis. Chem Biol Interact 436:112184. https:\/\/doi.org\/10.1016\/j.cbi.2026.112184","journal-title":"Chem Biol Interact"},{"key":"5997_CR46","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00417-011-1755-0","volume":"249","author":"J Ye","year":"2011","unstructured":"Ye J, Wu H, Zhang H et al (2011) Role of benzalkonium chloride in DNA strand breaks in human corneal epithelial cells. Graefes Arch Clin Exp Ophthalmol 249:1681\u20131687. https:\/\/doi.org\/10.1007\/s00417-011-1755-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05997-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05997-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:02:43Z","timestamp":1792411363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05997-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":46,"alternative-id":["5997"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05997-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocols for rats and mice were approved by the Local Ethics Committee of Kazan Federal University (protocol No. 9 dated April 09, 2018) and followed standard protocols for animal handling and care. All rabbit experiments complied with the Ethical Principles in Animal Research and were approved by the Bioethics Committee of the Federal State Budgetary Educational Institution of Higher Education \u201cSt. Petersburg State Chemical Pharmaceutical University\u201d of the Ministry of Health of the Russian\u00a0Federation (protocols \u2116 Rabbits-1\/1-18 dated April 16, 2018 and \u2116 Rabbitts-4\/3-18 dated May 05, 2018).","order":1,"name":"Ethics","label":"Statement of human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}